DB18396InvestigationalVaccines
IFx-Hu2.0 is an investigational cancer vaccine. It is composed of plasmid DNA encoding the streptococcal membrane protein, Emm55, contained within a cationic polymer.
- Also known as
- Immunotherapeutic vaccine consisting of pAc/emm55, a plasmid DNA (pDNA), which codes for a modified immunogenic, streptococcal Emm55 protein, complexed with in vivo-jetPEI® polymer-based reagent linear polyethylenimine)
- Code names
- IFx-Hu2.0
What you can answer from here — as of October 23, 2025
Which companies are running trials of IFx-Hu2.0, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account